2m 2m 2m 2m 2m 2m 2m
ELICIO THERAPTCS (ELTX)
NASDAQ
$1.54-$0.02 (-1.28%)
Price as of Nov 13, 2026 2:16 PM EST- $44.2MMarket Cap
- -82.88%1-Year Change
- BiotechnologyIndustry
ELICIO THERAPTCS (ELTX)
$1.54-$0.02 (-1.28%)
ELTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.56 | ||
Change | -$0.07 (-4.29%) | ||
Open | $1.59 | ||
High | $1.65 | ||
Low | $1.55 | ||
Previous Close | $1.63 | ||
Volume | 232,812 | ||
30-Day Average Volume | 322,575 | ||
1-Week Change | 11.43% | ||
1-Month Change | -17.02% | ||
1-Year Change | -82.88% | ||
3-Year Change | -73.42% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 28.3M | ||
Total Assets | $39.6M | ||
Market Cap | $44.2M | ||
Enterprise Value | $22.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.0M | ||
Free Cash Flow | -$10.4M | ||
EBIT | -$7.9M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $24.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue